Dry powder inhaler market seen reaching $28.16 billion by 2030

The Business Research Company says the dry powder inhaler market will grow from $22.18 billion in 2025 to $28.16 billion by 2030, driven by rising asthma and COPD cases, smart inhaler adoption and digital respiratory care. North America led the market in 2025, while new report features include TAM analysis, forecasting dashboards and trend graphics.

Why it matters: - Dry powder inhalers are a core delivery system for asthma, COPD and other respiratory diseases. - The market’s growth points to continued demand for at-home and targeted respiratory treatment. - New device features, digital monitoring and eco-friendly designs are becoming a bigger part of the competitive landscape.

What happened: - The Business Research Company released an outlook for the global dry powder inhaler market. - The market is projected to rise from $22.18 billion in 2025 to $23.25 billion in 2026. - The forecast puts the market at $28.16 billion by 2030. - The report links growth to rising asthma and COPD prevalence, broader acceptance of inhalation therapy and more accessible home-based respiratory care. - North America was the largest dry powder inhaler market in 2025.

The details: - Dry powder inhalers deliver medication to the lungs in powder form. - Effective use requires the patient to inhale quickly and deeply. - The devices are used to manage asthma, COPD and cystic fibrosis. - The report cites a December 2023 JAMA Network Open study projecting global COPD cases could reach nearly 600 million by 2050, a 23% increase in prevalence. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - New report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report also adds key technology coverage and future trend analysis. - A free sample is available here. - The full report is available here.

Between the lines: - The market forecast suggests respiratory care is moving toward more connected, personalized and adherence-focused treatment. - Smart inhalers, remote patient monitoring and digital health ecosystems are emerging as the next battleground for device makers. - Demand for portable, user-friendly and dose-precise devices is likely to shape product design. - North America’s lead suggests strong current adoption, but the report points to broader geographic growth as access and awareness improve.

What's next: - The market is expected to keep expanding through 2030 at a 4.9% CAGR. - Digitally controlled inhalers and multi-dose platforms are expected to see more adoption. - Manufacturers are likely to push more eco-friendly and connected products as healthcare systems adopt remote monitoring tools. - The report positions personalization and digital integration as the main growth themes to watch.

The bottom line: - Dry powder inhalers remain a steady-growth category, but the next phase of competition will center on smart features, patient adherence and digital care integration.